A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
Status:
Completed
Trial end date:
2018-12-23
Target enrollment:
Participant gender:
Summary
Phase 1, single center study to assess pharmacokinetic profiles of rotigotine after single
dose of LY03003 and daily patch application of Neupro in Healthy Volunteers